Pure Global AI
NCT06370390Not yet recruiting

Community-based Group Rehabilitation Program for Stroke Patients With Dysphagia

Community-based Group Rehabilitation Program for Stroke Patients With Dysphagia: a Randomized Controlled Trial
Copka SonpashanClinicalTrials.govbehavioral
Study focus
Disease/Condition
Stroke
Drug/Device/Intervention
swallowing function training
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Copka Sonpashan
Funder
Chao Phya Abhaibhubejhr Hospital
Timeline & enrollment
Phase
N/A
Start date
Apr 01, 2024
End date
Jun 01, 2024
Enrollment
200 participants
Primary outcome

Standardized Swallowing Assessment Scale

Summary

Community-based exercise programs have demonstrated potential for implementation in older
 adults; however, it remains imperative to ascertain whether this strategy will yield
 comparable benefit in stroke patients with dysphagia.Participants were randomly assigned to
 either the intervention group or the control group. Patients in the intervention group
 received swallowing function training in community public spaces for 5 days every week for
 four-week period (60 minutes per day). Patients in the control group received no
 intervention. Penetration-Aspiration Scale and Standardized Swallowing Assessment (SSA),
 depressive symptoms (Geriatric Depression Scale-15), and meal duration were assessed before
 and after all the treatment.

ICD-10 classifications
Stroke, not specified as haemorrhage or infarctionSequelae of stroke, not specified as haemorrhage or infarctionCerebral infarctionFamily history of strokeCerebral infarction, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06370390
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06370390 through Pure Global AI's free database. This phase not specified trial is sponsored by Copka Sonpashan and is currently Not yet recruiting. The study focuses on Stroke. Target enrollment is 200 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.